Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for June 2011
June 1, 2011
- Teva, Pfizer Settle Patent Dispute
- AVEO Pharmaceuticals Enters into Worldwide License Agreement with Centocor Ortho Biotech to Develop and Commercialize RON-Targeted Antibodies
- FDA Drug Safety Communication: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone
- Grifols and Talecris Biotherapeutics Announce the FTC Has Accepted the Consent Agreement for Public Comment
- Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
- A new Chief Executive Officer to strengthen BioAlliance Pharma's growth
June 2, 2011
- Oral Drug Costs Offer Bitter Pill
- J&J Accused of Hiding the Tendon Risks of Levaquin
- Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY (ipilimumab) and Vemurafenib
- Companies Report Increased Philanthropic Giving in 2010
- SC Attorney General's Office Sues Maker of Avandia
- N.C. House Oks Bill to Rein in Lawsuits
- After Sale, CEO Will Move On
- Spanish Buyer Set to Take Over Talecris
- Diamyd Medical: Diamyd closes European Phase III study
- UBM Medica Launches '1-Click Movement for Millions' - Program Supports Doctors Without Borders' Global Relief Efforts
June 3, 2011
- FDA Drug Safety Communication: No increase in risk of cancer with certain blood pressure drugs--Angiotensin Receptor Blockers (ARBs)
- Physician, Researcher Charged with Falsifying Clinical Drug Trial
- Theratechnologies Lays Off 24 Staff as it Reworks its Research and Development
- FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer
- Mylan Gets Approval for Generic Effexor XR
- Physician, Researcher Charged With Falsifying Clinical Drug Trial
- Insider Trading Charge Against Government Chemist Accused of Using Drug Data
- Impax Seeks Generic Detrol Approval; Pfizer Sues
- Grifols Announces the Completion of its Acquisition of Talecris and the Listing of its ADSs on NASDAQ
June 6, 2011
- Watson Confirms Viagra Patent Challenge
- Drug Firms to Cut Vaccine Prices
- Ipsen Announces Discontinuation of the Development of Irosustat in Monotherapy
- BioSante Pharmaceuticals Announces Lifting of Clinical Hold on GVAX Prostate Cancer Vaccine
- Launch of SONIAS LD and SONIAS HD in Japan
- American Regent Initiates Nationwide Voluntary Recall of Methyldopate HCL Injection, USP 5 mL Single Dose Vial Due to Glass Particulates
- Pharmaceutical Giant AstraZeneca Agrees to Pay $250,000 to Settle Sex Discrimination Lawsuit Brought by US Labor Department
June 7, 2011
- Paul and Mira Sorvino Announce Nationwide Recipe Contest
- Lawyers Seek Leniency for Ex-Synthes Executives
- Two Leading Drug Firms Join Forces for Next-Generation Malaria Vaccine
- Biosante Plans Trial for Prostate Cancer Vaccine
- Teva Says Immune System Drug Met Goal in Study
- Corcept Therapeutics Details Corlux Study Results
- Exelixis Reports Deaths in Cancer Drug Study
- Roche and Merck Collaborate to Develop Diagnostic Tests for Merck's Investigational Cancer Therapies
June 8, 2011
- CEO Sees Few Cuts at Talecris
- Schuette Files Lawsuit to Recover Millions in Taxpayer Funds from Drug Wholesaler, Publisher for Inflated Drug Prices
- Appeals Court Affirms Patent Decision in J&J Case
- High Court Rejects Stanford's Bid to Revive Lawsuit with Roche Over AIDS Treatment Patents
- Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
- Pfizer Conducts First ?Virtual? Clinical Trial Allowing Patients to Participate Regardless Of Geography
- Pfizer Lung Cancer Pill Could Double Survival, Study Shows
- APP Pharma Launches Generic Breast Cancer Drug
- Gen-Probe Shares Plunge As Sale Appears to Falter
- Somaxon and Paladin Announce Silenor Ex-US Collaboration
- Top 100 Medical Device Companies 2011- Press Release
- Pfizer Says It Is Planning Another $1 Billion in Cost-Cutting Steps
- Dohmen Company Acquires San Francisco-based MedComm Solutions
- Lowe and Partners Rebrands Global Healthcare Network as ICC Lowe
- FDA OKs Updated Label for Lilly Insulin Humalog
- U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose -- 80 mg -- and Updated Drug Interaction Information
June 9, 2011
- Pfizer to Invest $100 Million in R&D in Boston Area
- EMD Serono: Patient Enrollment Completed for Cilengitide's Pivotal Phase III Trial CENTRIC
- U.S. District Court Rules in Favor of Lilly in Amylin Litigation
- Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
- UCB, Inc. Resolves Investigation of Past Keppra Marketing and Promotional Activities
June 10, 2011
- WPI Partnering with Abbott, Bristol-Myers Squibb, and Shire for New Center at Gateway Park
- Baxter Loses First Heparin case
- FDA Works to Lessen Drug Shortage Impact
- Novo Nordisk Inc. Reaches Agreements With US Department of Justice
- Update on Ongoing European Review of Pioglitazone?Containing Medicines
- Sucking Up to the Boss May Move You Up and Keep You Healthy
- IMS Strengthens Payer Capabilities with Acquisition of Med-Vantage
June 13, 2011
- FDA Approves Redesigned Labels for Some Merck Drugs
- Merck and Hanwha Chemical Corporation Establish Global Strategic Collaboration to Develop and Commercialize Biosimilar Candidate
- Gilead Sciences Receives Subpoena from U.S. Department of Justice
- Tibet Pharmaceuticals Announces New CEO
- Synageva BioPharma and Trimeris Announce Merger Agreement
- Forest Laboratories Receives Notice of Director Nominations
- Federal Government Takes Action Against Drug Manufacturer and Distributor
- Little Support for GOP Plan to Privatize Medicare: Poll
- Unigene Continues Solid Execution of Focused Turnaround Strategy and Monetizes Non-Core Asset with the Termination of China Joint Venture
- Teva Signs $4 Billion Syndicated Credit Facilities
June 14, 2011
- Synageva BioPharma to Acquire Trimeris
- Pfizer Goes to Court to Protect Exclusive Rights to Sell Viagra
- Brain Disorders Research Under Threat As Drug Firms Pull Out
- Boulder's Array Biopharma Cuts 20 Percent of Workforce
- Array BioPharma Announces Restructuring
- Important New Research using Immunocal Shows Promise in Lou Gehrig's Disease
- Arecor and GSK Form Collaboration to Advance New Vaccines
- Neuralstem Updates ALS Clinical Trial Progress
- Baxter Introduces First Ready-to-Use IV Amiodarone
- GSK to Purchase Shenzhen Neptunus Stake in Previously Formed Joint Venture for Influenza Vaccines in China
June 15, 2011
- Pharmaceutical Novo Nordisk Settles Health Care Fraud Allegations
- Pharmaceutical Novo Nordisk Settles Health Care Fraud Allegations
- Cordis Announces Discontinuation of Nevo Sirolimus-Eluting Coronary Stent
- Researchers Question Safety of Mist Inhalers for Delivering Common Drug for Chronic Lung Disease
- Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
- Dr. Reddy's Receives FDA Warning Letter
- Special Interest Titans in Drug Coupon Duel
- J&J Names Former Aetna CEO to Its Board
- Glaxo Tax Disputes Could Cost Philly Area School Districts Millions
- Dr. Reddy's Gets FDA Warning Letter Over Mexico Site
- Boehringer Ingelheim and Lilly's New Type 2 Diabetes Treatment Tradjenta (Linagliptin) Tablets for Adults Now Available in U.S. Pharmacies
- Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan
- Adolor Corporation Announces Agreement to Acquire Full Ownership of Entereg (alvimopan)
- Takeda Filed Actos Patent Litigations Against Generic Companies in Japan
June 16, 2011
- Rocky Mountain Biological Laboratory Expands Board of Trustees, Appoints Dr. Jeremy Levin of Bristol-Myers Squibb
- Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of Actos (pioglitazone HCl)
- Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
- Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
- Surmodics Shares Sink After J&J Stent Announcement
- Regeneron Jumps on Positive Review for Eye Drug
- J&J Stent Maker to Cut 1,000 Jobs
- NC Senate OKs Liability Lawsuits Bill
- Endologix Receives FDA Approval for Stent System
- Bristol-Myers' Nulojix Approved
- Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer
- Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
- Novartis Begins Construction of New State-of-the-Art Pharmaceutical Manufacturing Plant in St. Petersburg, Russia
- FDA MedWatch - Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events
June 17, 2011
- EpiCept Announces Resignation of Board Member
- Watson Confirms Court Decision Rejecting Teva's Motion to Prevent Launch of Generic Seasonique
- Vaccinating Girls Will Cut Rates of Cervical Cancer, Study Finds
- GELA, the Premier Cooperative Group in Adult Lymphoma Research Choses Revlimid for Major Study in Follicular Lymphoma
- K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
- AstraZeneca Extends Its Investment in Russia With New Predictive Science Centre in St Petersburg
- Study Finds Shingles May Be Related to Elevated Risk of Multiple Sclerosis
- Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of Risperdal Tablets and One Lot of Risperidone Tablets
June 20, 2011
- Concert Announces Milestone Achievement in GlaxoSmithKline Collaboration
- Mylan Defeats Teva's Motion for Summary Judgment on Copaxone; Court Orders Trial on Inequitable Conduct Defense to Commence July 11, 2011
- Pfizer Selects Exco InTouch?s Novel eDiary Technologies to Initiate First Ever Patient-Centered Clinical Trial
- FDA Examines Ways to Improve Consumer Understanding of Prescription Drug Ads
June 21, 2011
- Icagen and Pfizer Initiate Nav 1.7 Phase I Multiple Ascending Dose Study
- FDA Oks Generic Versions of Antibiotic Levaquin
- Legendary Musician Gregg Allman Joins Merck and American Liver Foundation to Launch Tune In to Hep C Public Awareness Campaign
- Merck Loses $473M Tax Appeal in Schering Case
- Transfer of Distribution Rights for SSRI "Luvox Tablets"
- Abbott and Biotest Announce Global Agreement to Develop and Commercialize Novel Antibody for Autoimmune Diseases
- Hawaii Biotech Climbs Back Out of Bankruptcy
June 22, 2011
- Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
- European Commission Approves Inclusion of Anti-JC Virus Antibody Status as a PML Risk Factor in Tysabri Labeling
- Shareholder Balks at Trimeris Deal
- AstraZeneca Edges Higher After Confirming $1.8bn Astra Tech Sale
- Novartis' Ilaris Gets Thumbs Down As Gout Treatment
- Novartis Says Panel Votes Against Arthritis Drug
- CSL Biotherapies Statement on FDA Warning Letter
- FDA Sends CSL Biotherapies Warning Letter Over Plant Conditions.
- Sanofi Pasteur opens $100M R&D centre in Canada
- Chandler Chicco Companies and Chamberlain Communications Group Join Forces to Create Unrivalled Health Communications Network
June 23, 2011
- J&J Opens Development Center in China
- Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
- Diamyd Medical: Diamyd Initiates Closure of US Phase III study
- Panel to Pregnant Moms: Get Whooping Cough Shots
- EMD Serono, Inc. Committed to Transparency in Interactions with Healthcare Professionals and Organizations
- BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
- Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery
- Anacor Pharmaceuticals Announces GSK Has Initiated Two Phase 2 Trials of GSK ?052 in Complicated Urinary Tract Infections and Complicated Intra-Abdominal Infections
- MSMB Capital Management Proposes Acquisition of SeraCare for $4.25 Per Share
- FDA Sends Letter to Novartis Regarding Promotional Material for Focalin XR
- FDA Sends Letter to Dow Pharmaceutical Sciences Regarding Acanya Website
- Analysts: Eliquis Works Better than Coumadin
- Supreme Court: Generic Drugs Not Liable for Warnings
- Roche Sets Up R&D Institute in France to Foster Collaborative Translational Research
- Allozyne Seeks Stock Listing Via Merger With Former NeoRx
- U.S. Supreme Court Strikes Down Vermont Prescription Data Restriction Law
June 24, 2011
- Conte Foundation: Supreme Court Focuses Reglan Liability Back on Brand-Name Company
- Labopharm Announces Reduction of Angelini Labopharm's Oleptro Sales Force
- Evotec and Roche to jointly develop biomarkers in oncology
- Genmab Announces Zalutumumab Update
- MonoSol Rx Aligns Executive Leadership to Maximize Growth Opportunities, Operational Excellence and R&D Pipeline
- Supreme Court Strikes Down Vermont Prescription Privacy Law
- GSK Statement on University of East Anglia Study Examining Health Impacts of Anticholinergic Medicines for Over 65s
- GSK Statement on Agreements With State Attorneys General on Former Cidra Manufacturing Facility
- FDA Modifies Dosing Recommendations for Erythropoiesis-Stimulating Agents
- Janssen Products, LP Modifies Prescribing Information for PROCRIT (Epoetin alfa) in Chronic Kidney Disease
June 27, 2011
June 28, 2011
- Drug Trial Raises Ethics Questions
- Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities
- Icagen Shares Buoyed By Reports of Possible Pfizer Takeover
- Humira to Assume Lipitor's Crown As Pfizer Feels the Heat From Sanofi and Novartis
- Amgen Seeks FDA OK for Additional Xgeva Use
- Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize a New Fixed-Dose Combination of Cobicistat and Prezista®
- FDA Sends Letter to Cephalon Regarding Trisenox Website
- Merck Expands Distribution Deal With UPS
June 29, 2011
- Lilly Plans to Expand Biotech R&D
- U.S. Senate Bill Designed to Alert FDA to Potential Drug Shortages
- AstraZeneca and PTC Therapeutics Announce Strategic Oncology Drug Discovery Collaboration With Potential Extension to Other Therapeutic Areas
- Actelion Provides an Update on the Award Provision in Regard to Asahi Litigation
- Pfizer and ChemRar High Tech Center Announce Plans to Explore Innovative Medical Research and Development Partnership in Russia
- Kyowa Hakko Kirin Announces a Plan to Build a New Pharmaceutical Plant
- Par Pharmaceutical Companies Announces a Restructuring of Its Branded Division, Strativa Pharmaceuticals, to Maximize Profitability
- Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer
- Monthly Roundup - June 2011
June 30, 2011
- Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations
- Astellas' Prosidion Subsidiary Sells Dipeptidyl Peptidase IV (DPP-IV) Patent Estate and Associated Royalty Interest to Royalty Pharma for USD 609 Million
- SDI Releases Company Image 2011: Pfizer and Bayer Rank 1st and 2nd with OB/GYNs
- Meda and Valeant sign collaboration agreement
- Major Report Urges Changes in Chronic Pain Treatment
- FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility
- Valeant Pharma Acquires Rights for Skin Medications in U.S., Canada, Mexico
- Kailua Woman Sues Merck After Breaking Bone
- Forest Laboratories, Inc. Announces Commercial Availability of VIIBRYD in Pharmacies
- NJ Biotech Exec Crowley Say No US Senate Run
- Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
- Forest Laboratories, Inc. Announces Commercial Availability of VIIBRYD in Pharmacies
